{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:41:43Z","timestamp":1792892503453,"version":"4.5.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Neurodegenerative diseases such as Alzheimer\u2019s, Parkinson\u2019s, and Huntington\u2019s are on the rise and pose significant challenges due to the lack of effective treatments. This review critically examines the neuroprotective effects of various natural products derived from plants, marine organisms, and fungi. Natural products have long been used in traditional medicine and are gaining attention in modern drug discovery for their unique properties. The review explains how these natural products can protect neurons by influencing the key biological pathways involved in neurodegeneration. It discusses mechanisms including antioxidant effects, anti-inflammatory actions, modulation of cellular signalling, and support for mitochondrial function. A systematic literature search was conducted to minimize bias and ensure rigorous study selection. Preclinical studies using animal models and cell cultures show that secondary metabolites like polyphenols, alkaloids, and terpenoids can significantly reduce neuronal damage. Some clinical trials have shown promising results. However, challenges such as bioavailability, standardization, and dosage must be addressed to translate these findings into clinical practice. The review also evaluates the potential synergy of combining natural products with conventional treatments, offering a complementary therapeutic approach. Natural products represent a promising avenue for developing innovative treatments for neurodegenerative diseases. The review highlights key research gaps and proposes future directions. Future studies should focus on overcoming existing challenges and refining these natural products to improve their efficacy and safety in clinical settings. The application of existing knowledge has the potential to significantly enhance the quality of life for individuals affected by neurodegenerative diseases.<\/jats:p>","DOI":"10.3389\/fphar.2025.1529194","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:08:48Z","timestamp":1742368128000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":61,"title":["Natural products in neurodegenerative diseases: recent advances and future outlook"],"prefix":"10.3389","volume":"16","author":[{"given":"L.","family":"Nahar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Charoensup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulyash","family":"Kalieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kvasnica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. D.","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1177392819866412","DOI":"10.1177\/1177392819866412","article-title":"Bacopa monnieri, a neuroprotective lead in Alzheimer disease: a review on its properties, mechanisms of action, and preclinical and clinical studies","volume":"13","author":"Abdul Manap","year":"2019","journal-title":"Drug Target Insights"},{"key":"B2","doi-asserted-by":"publisher","first-page":"132135","DOI":"10.1016\/j.foodchem.2022.132135","article-title":"Epigallocatechin 3-gallate: from green tea to cancer therapeutics","volume":"379","author":"Alam","year":"2022","journal-title":"Food Chem."},{"key":"B3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/biof.118","article-title":"Neuroprotective properties of resveratrol in different neurodegenerative disorders","volume":"36","author":"Albani","year":"2010","journal-title":"Biofactors"},{"key":"B4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/pharmaceutics15010212","article-title":"Therapeutic potential of natural compounds in neurodegenerative diseases: insights from clinical trials","volume":"15","author":"Andrade","year":"2023","journal-title":"Pharmaceutics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fnagi.2020.00103","article-title":"Resveratrol derivatives as potential treatments for Alzheimer\u2019s and Parkinson\u2019s disease","volume":"12","author":"Arbo","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12986-024-00792-1","article-title":"Unraveling the therapeutic efficacy of resveratrol in Alzheimer\u2019s disease: an umbrella review of systematic evidence","volume":"21","author":"Azargoonjahromi","year":"2024","journal-title":"Nutr. Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11481-014-9569-6","article-title":"Potential neuroprotective activity of Ginseng in Parkinson\u2019s disease: a Review","volume":"10","author":"Burgos","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/md19010024","article-title":"Benefits under the sea: the role of marine compounds in neurodegenerative disorders","volume":"19","author":"Catanesi","year":"2021","journal-title":"Mar. Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.37256\/fse.3120221166","article-title":"Neuroprotective and anticarcinogenic properties of Hericium mushrooms and the active constituents associated with these effects: a Review","volume":"31","author":"Chen","year":"2022","journal-title":"Food Sci. Engine."},{"key":"B10","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2174\/1871527318666191114093749","article-title":"Omega-3 fatty acids as druggable therapeutics for neurodegenerative disorders","volume":"18","author":"Chitre","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s12640-022-00526-2","article-title":"Can berberine serve as a new therapy for Parkinson\u2019s disease?","volume":"40","author":"Dadgostar","year":"2022","journal-title":"Neurotoxic. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/bs.armc.2020.02.009","article-title":"Neuroprotective natural products","volume":"55","author":"Das","year":"2020","journal-title":"Annu. Rep. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/nutraceuticals4020011","article-title":"Resveratrol and neuroinflammation: total-scale analysis of the scientific literature","volume":"4","author":"Dos Santos","year":"2024","journal-title":"Nutraceuticals"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1007\/s10787-024-01492-1","article-title":"The regulating effect of curcumin on NF-\u03baB pathway in neurodegenerative diseases: a review of the underlying mechanisms","volume":"32","author":"Esmaealzadeh","year":"2024","journal-title":"Inflammopharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/md19030165","article-title":"Marine natural products: promising candidates in the modulation of gut-brain axis towards neuroprotection","volume":"19","author":"Fakhri","year":"2021","journal-title":"Mar. Drugs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"718188","DOI":"10.3389\/fnins.2021.718188","article-title":"Green tea polyphenol epigallocatechin-gallate in amyloid aggregation and neurodegenerative diseases","volume":"15","author":"Fernandes","year":"2021","journal-title":"Front. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1305933","DOI":"10.3389\/fimmu.2023.1305933","article-title":"Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression","volume":"14","author":"Fornari Laurindo","year":"2023","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/biom11050767","article-title":"Green tea epigallocatechin-3-gallate (EGCG) targeting protein misfolding in drug discovery for neurodegenerative diseases","volume":"11","author":"Gon\u00e7alves","year":"2021","journal-title":"Biomolecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.3969\/j.issn.1673-5374.2013.21.009","article-title":"Oxidative stress, mitochondrial damage and neurodegenerative diseases","volume":"8","author":"Guo","year":"2013","journal-title":"Neural Regen. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry."},{"key":"B22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"fcad356","DOI":"10.1093\/braincomms\/fcad356","article-title":"Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants","volume":"6","author":"Houldsworth","year":"2024","journal-title":"Brain Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/md17040221","article-title":"Marine-derived natural compounds for the treatment of Parkinson\u2019s disease","volume":"17","author":"Huang","year":"2019","journal-title":"Mar. drugs"},{"key":"B25","doi-asserted-by":"publisher","first-page":"107100","DOI":"10.1016\/j.phrs.2024.107100","article-title":"Novel nano-drug delivery system for natural products and their application","volume":"201","author":"Huang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3389\/fphar.2018.01555","article-title":"Plant extracts and phytochemicals targeting \u03b1-synuclein aggregation in Parkinson's disease models","volume":"9","author":"Javed","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"13021","DOI":"10.3390\/ijms241613021","article-title":"From pathogenesis to therapeutics: a review of 150 years of Huntington\u2019s disease research","volume":"24","author":"Jiang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"a024240","DOI":"10.1101\/cshperspect.a024240","article-title":"Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies","volume":"7","author":"Jimenez-Sanchez","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"115215","DOI":"10.1016\/j.biopha.2023.115215","article-title":"Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: from chemistry to medicine","volume":"165","author":"Jin","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/bs.armc.2020.02.003","article-title":"\u201cIn \u201cmedicinal natural products \u2013 a disease-focused approach\u201d (editors: Sarker, S. D. and Nahar, L.), Nephroprotective natural products,\u201d Annual Reports in medicinal chemistry (UK: Elsevier)","volume":"55","author":"Jivishov","year":"2020","journal-title":"Annu. Rep. Med. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1136\/jnnp.2003.028761","article-title":"Mucuna pruriens in Parkinson\u2019s disease: a double blind clinical and pharmacological study","volume":"75","author":"Katzenschlager","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7860650","DOI":"10.1155\/2019\/7860650","article-title":"Dietary supplementation of the antioxidant curcumin halts systemic LPS\u2010induced neuroinflammation\u2010associated neurodegeneration and memory\/synaptic impairment via the JNK\/NF\u2010\u03baB\/Akt signaling pathway in adult rats","volume":"1","author":"Khan","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jgr.2017.03.011","article-title":"Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: Past findings and future directions","volume":"42","author":"Kim","year":"2018","journal-title":"J. Ginseng Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"B35","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.expneurol.2006.02.062","article-title":"Oral administration of green tea epigallocatechin-3-gallate (EGCG) reduces amyloid-beta deposition in transgenic mouse model of Alzheimer's disease","volume":"2","author":"Li","year":"2006","journal-title":"Exp. Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/md21050261","article-title":"Marine macroalgae polyphenols as potential neuroprotective antioxidants in neurodegenerative diseases","volume":"21","author":"Lomartire","year":"2023","journal-title":"Mar. Drugs."},{"key":"B37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/ph13090242","article-title":"Marine natural products, multitarget therapy and repurposed agents in Alzheimer\u2019s disease","volume":"13","author":"Martins","year":"2020","journal-title":"Pharmaceuticals"},{"key":"B38","volume-title":"Chemistry for pharmacy Students: General, organic and natural product Chemistry","author":"Nahar","year":"2019"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s10787-020-00751-1","article-title":"Alzheimer\u2019s disease: natural products as inhibitors of neuroinflammation","volume":"28","author":"Olajide","year":"2020","journal-title":"Inflammopharmacology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/antiox13020240","article-title":"Mitochondria dysfunction and neuroinflammation in neurodegeneration: who comes first?","volume":"13","author":"Peggion","year":"2024","journal-title":"Antioxidants (Basel)."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.3390\/molecules26175327","article-title":"Therapeutic potential of natural products in treating neurodegenerative disorders and their future prospects and challenges","volume":"26","author":"Rahman","year":"2021","journal-title":"Molecules"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1523\/JNEUROSCI.1521-05.2005","article-title":"Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice","volume":"25","author":"Rezai-Zadeh","year":"2005","journal-title":"J. Neurosci. Official J. Soc. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s43088-023-00407-3","article-title":"Neuroprotective compounds from marine invertebrates","volume":"12","author":"Rivai","year":"2023","journal-title":"J. Basic. Appl. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2220\/biomedres.40.125","article-title":"Improvement of cognitive functions by oral intake of Hericium erinaceus","volume":"40","author":"Saitsu","year":"2019","journal-title":"Biomed. Res."},{"key":"B45","volume-title":"In \u201cturmeric: the Genus Curcuma\u201d (editors: Ravindran, P. N., Babu, K. N. and Sivaraman, K.), bioactivity of turmeric","author":"Sarker","year":"2007"},{"key":"B46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/md21080451","article-title":"Marine-derived components: can they be a potential therapeutic approach to Parkinson\u2019s disease?","volume":"21","author":"Silva","year":"2023","journal-title":"Mari. Drugs."},{"key":"B47","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","article-title":"Neuroprotective and antioxidant Effect of Ginkgo biloba extract against AD and other neurological disorders","volume":"16","author":"Singh","year":"2019","journal-title":"Neurotherapeutics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3945\/an.114.007500","article-title":"Flavonoid-based therapies in the early management of neurodegenerative diseases","volume":"6","author":"Solanki","year":"2015","journal-title":"Adv. Nutr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2174\/1389200222666210203182716","article-title":"Withania somnifera in neurological disorders: Ethnopharmacological evidence, mechanism of action and its progress in delivery systems","volume":"22","author":"Syed","year":"2021","journal-title":"Curr. Drug Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jgr.2014.09.002","article-title":"Ginseng improves cognitive deficit via the RAGE\/NF-\u03baB pathway in advanced glycation end product-induced rats","volume":"39","author":"Tan","year":"2015","journal-title":"J. Ginseng Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"112610","DOI":"10.1016\/j.biopha.2021.112610","article-title":"Therapeutic promise of carotenoids as antioxidants and anti-inflammatory agents in neurodegenerative disorders","volume":"146","author":"Tanvir","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3390\/antiox12101883","article-title":"Neuroprotective properties of berberine: molecular mechanisms and clinical implications","volume":"12","author":"Tian","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.3390\/ijms25073845","article-title":"Huntington\u2019s disease: complex pathogenesis and therapeutic strategies","volume":"25","author":"Tong","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ibneur.2023.01.006","article-title":"Pathways to healing: plants with therapeutic potential for neurodegenerative diseases","volume":"14","author":"Tyler","year":"2023","journal-title":"IBRO Neurosci. Rep."},{"key":"B58","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41702-019-0044-0","article-title":"Advances in research on the active constituents and physiological effects of Ganoderma lucidum","volume":"3","author":"Yang","year":"2019","journal-title":"Biomed. Dermatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"14753","DOI":"10.3390\/ijms232314753","article-title":"Pathogenesis of \u03b1-synuclein in Parkinson\u2019s disease: from a neuron-glia crosstalk perspective","volume":"23","author":"Yi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainres.2008.12.031","article-title":"Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus","volume":"1256","author":"Zhao","year":"2009","journal-title":"Brain Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1529194\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:08:52Z","timestamp":1742368132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1529194\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":62,"alternative-id":["10.3389\/fphar.2025.1529194"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1529194","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"article-number":"1529194"}}